| 14702 | A | 213532 | 002 | LEVETIRACETAM | INJECTABLE;INTRAVENOUS | INJECTABLE | INTRAVENOUS | LEVETIRACETAM IN SODIUM CHLORIDE | NEXUS PHARMS | 1GM/100ML (10MG/ML) | AP | ["AP"] | 2020-07-06 | Jul 6, 2020 | No | No | No | RX | NEXUS PHARMACEUTICALS INC | 2478d0173f02875a3f78e9730f089ec64513cc309340481f17dc3bf2a087f145 |
| 14703 | A | 213532 | 003 | LEVETIRACETAM | INJECTABLE;INTRAVENOUS | INJECTABLE | INTRAVENOUS | LEVETIRACETAM IN SODIUM CHLORIDE | NEXUS PHARMS | 1.5GM/100ML (15MG/ML) | AP | ["AP"] | 2020-07-06 | Jul 6, 2020 | No | No | No | RX | NEXUS PHARMACEUTICALS INC | e34d1e98524559a79a101a8bae750d02015b3868361b153f1595a94827327255 |
| 14704 | A | 213532 | 001 | LEVETIRACETAM | INJECTABLE;INTRAVENOUS | INJECTABLE | INTRAVENOUS | LEVETIRACETAM IN SODIUM CHLORIDE | NEXUS PHARMS | 500MG/100ML (5MG/ML) | AP | ["AP"] | 2020-07-06 | Jul 6, 2020 | No | No | No | RX | NEXUS PHARMACEUTICALS INC | 2543778be01670fbed16ef0367ebc99e69dc7b1104f371d652c96d86c3320e29 |
| 14705 | N | 021625 | 001 | ASCORBIC ACID; BIOTIN; CYANOCOBALAMIN; DEXPANTHENOL; ERGOCALCIFEROL; FOLIC ACID; NIACINAMIDE; PYRIDOXINE HYDROCHLORIDE; RIBOFLAVIN 5'-PHOSPHATE SODIUM; THIAMINE HYDROCHLORIDE; VITAMIN A; VITAMIN E; VITAMIN K | INJECTABLE;INTRAVENOUS | INJECTABLE | INTRAVENOUS | M.V.I. ADULT | HOSPIRA | 200MG/VIAL;0.06MG/VIAL;0.005MG/VIAL;15MG/VIAL;0.005MG/VIAL;0.6MG/VIAL;40MG/VIAL;6MG/VIAL;3.6MG/VIAL;6MG/VIAL;1MG/VIAL;10MG/VIAL;0.15MG/VIAL | | [] | 2004-01-30 | Jan 30, 2004 | No | Yes | Yes | RX | HOSPIRA INC | fc1371e7a7525bcef68f73c4f59def07700b76eb74fd394d9ebc70a932f15176 |
| 14706 | N | 021643 | 001 | ASCORBIC ACID; BIOTIN; CYANOCOBALAMIN; DEXPANTHENOL; ERGOCALCIFEROL; FOLIC ACID; NIACINAMIDE; PYRIDOXINE HYDROCHLORIDE; RIBOFLAVIN 5'-PHOSPHATE SODIUM; THIAMINE HYDROCHLORIDE; VITAMIN A; VITAMIN E; VITAMIN K | INJECTABLE;INTRAVENOUS | INJECTABLE | INTRAVENOUS | M.V.I. ADULT (PHARMACY BULK PACKAGE) | HOSPIRA | 200MG/5ML;0.06MG/5ML;0.005MG/5ML;15MG/5ML;0.005MG/5ML;0.6MG/5ML;40MG/5ML;6MG/5ML;3.6MG/5ML;6MG/5ML;1MG/5ML;10MG/5ML;0.15MG/5ML | | [] | 2004-02-18 | Feb 18, 2004 | No | Yes | Yes | RX | HOSPIRA INC | eb5d3b404f21d547c160a05a08a8f7dd72e4be4d224e36bc217d9b4392fe817d |
| 14707 | A | 075811 | 001 | MESNA | INJECTABLE;INTRAVENOUS | INJECTABLE | INTRAVENOUS | MESNA | FRESENIUS KABI USA | 100MG/ML | AP | ["AP"] | 2001-04-26 | Apr 26, 2001 | No | No | No | RX | FRESENIUS KABI USA LLC | 3c75aed399c921a72735bb64c0f1c413851252883a1ae9905bde215571e028bb |
| 14708 | A | 206992 | 001 | MESNA | INJECTABLE;INTRAVENOUS | INJECTABLE | INTRAVENOUS | MESNA | GLAND PHARMA LTD | 100MG/ML | AP | ["AP"] | 2017-12-18 | Dec 18, 2017 | No | No | No | RX | GLAND PHARMA LTD | 8596da934576fa8e0f67337f2936e7e97e8eb5ad99a4456486b4d78c46f90bb2 |
| 14709 | A | 076488 | 001 | MESNA | INJECTABLE;INTRAVENOUS | INJECTABLE | INTRAVENOUS | MESNA | MYLAN INSTITUTIONAL | 100MG/ML | | [] | 2012-03-08 | Mar 8, 2012 | No | No | No | DISCN | MYLAN INSTITUTIONAL LLC | 707610899f60bdf0350c6b7f2f3b0e57b06c461b616a12d71fc07cd01407d5f3 |
| 14710 | A | 203364 | 001 | MESNA | INJECTABLE;INTRAVENOUS | INJECTABLE | INTRAVENOUS | MESNA | MYLAN LABS LTD | 100MG/ML | | [] | 2014-07-18 | Jul 18, 2014 | No | No | No | DISCN | MYLAN LABORATORIES LTD | 2121c5eb36cf0d878a29e44415345c87c4da9faf63a0730e7637cd7b8de5ef0d |
| 14711 | A | 090913 | 001 | MESNA | INJECTABLE;INTRAVENOUS | INJECTABLE | INTRAVENOUS | MESNA | SAGENT PHARMS INC | 100MG/ML | AP | ["AP"] | 2010-04-13 | Apr 13, 2010 | No | No | No | RX | SAGENT PHARMACEUTICALS INC | 0b34c6a3937311080a1acb7e73536dcc14c50014a407697a642c43f047cdfd5a |
| 14712 | A | 075764 | 001 | MESNA | INJECTABLE;INTRAVENOUS | INJECTABLE | INTRAVENOUS | MESNA | TEVA PHARMS USA | 100MG/ML | | [] | 2001-04-27 | Apr 27, 2001 | No | No | No | DISCN | TEVA PHARMACEUTICALS USA | 8739eb0767a3e35ee3b37a3022d0271009ebfeeee6fdb6acf03570f4a568fec8 |
| 14713 | A | 075739 | 001 | MESNA | INJECTABLE;INTRAVENOUS | INJECTABLE | INTRAVENOUS | MESNA | WEST-WARD PHARMS INT | 100MG/ML | AP | ["AP"] | 2004-01-09 | Jan 9, 2004 | No | No | No | RX | WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD | 9a4829b352e8595771b3dc6c4969b765b032ecc092f51b6c74905efb1394a5d3 |
| 14714 | N | 019884 | 001 | MESNA | INJECTABLE;INTRAVENOUS | INJECTABLE | INTRAVENOUS | MESNEX | BAXTER HLTHCARE | 100MG/ML | AP | ["AP"] | 1988-12-30 | Dec 30, 1988 | No | Yes | Yes | RX | BAXTER HEALTHCARE CORP | 15fb82b9937faa8e0c00d5c7efb597ec4e63294c0a20c6766d90b2a17cd19291 |
| 14715 | A | 208366 | 001 | MICAFUNGIN SODIUM | INJECTABLE;INTRAVENOUS | INJECTABLE | INTRAVENOUS | MICAFUNGIN SODIUM | APOTEX | EQ 50MG BASE/VIAL | AP | ["AP"] | 2020-11-05 | Nov 5, 2020 | No | No | No | RX | APOTEX INC | fce890f924dfb9ed9893d0eff86f61509ff21ee2ee977e721dcfdd2bca6eb46b |
| 14716 | A | 208366 | 002 | MICAFUNGIN SODIUM | INJECTABLE;INTRAVENOUS | INJECTABLE | INTRAVENOUS | MICAFUNGIN SODIUM | APOTEX | EQ 100MG BASE/VIAL | AP | ["AP"] | 2020-11-05 | Nov 5, 2020 | No | No | No | RX | APOTEX INC | 7a8ac1df2e2237c070592a459d4f556c84813cf12ce17eb3a1fa705cd73f93b2 |
| 14717 | A | 207344 | 001 | MICAFUNGIN SODIUM | INJECTABLE;INTRAVENOUS | INJECTABLE | INTRAVENOUS | MICAFUNGIN SODIUM | FRESENIUS KABI USA | EQ 50MG BASE/VIAL | AP | ["AP"] | 2019-05-17 | May 17, 2019 | No | No | No | RX | FRESENIUS KABI USA LLC | e7dd8a48c9ec6701bda136747bf6e9f5703f23b9f92501ec597e20ba535650fe |
| 14718 | A | 207344 | 002 | MICAFUNGIN SODIUM | INJECTABLE;INTRAVENOUS | INJECTABLE | INTRAVENOUS | MICAFUNGIN SODIUM | FRESENIUS KABI USA | EQ 100MG BASE/VIAL | AP | ["AP"] | 2019-05-17 | May 17, 2019 | No | No | No | RX | FRESENIUS KABI USA LLC | 1d4f4f358fe460b657e4e84706bb33a0782a674355562792300c7217de24e52e |
| 14719 | N | 021357 | 001 | GADOBENATE DIMEGLUMINE | INJECTABLE;INTRAVENOUS | INJECTABLE | INTRAVENOUS | MULTIHANCE | BRACCO | 2.645GM/5ML (529MG/ML) | | [] | 2004-11-23 | Nov 23, 2004 | No | Yes | Yes | RX | BRACCO DIAGNOSTICS INC | 86a01f8b1ab5d7609a153efc07c205d301cf3ad825393c55a17cf0ad92cf1d8a |
| 14720 | N | 021357 | 002 | GADOBENATE DIMEGLUMINE | INJECTABLE;INTRAVENOUS | INJECTABLE | INTRAVENOUS | MULTIHANCE | BRACCO | 5.29GM/10ML (529MG/ML) | | [] | 2004-11-23 | Nov 23, 2004 | No | Yes | Yes | RX | BRACCO DIAGNOSTICS INC | 897c4a7864073feff8b3e7637d30e9b557cebf7770721d266457dca4c399ab71 |
| 14721 | N | 021357 | 003 | GADOBENATE DIMEGLUMINE | INJECTABLE;INTRAVENOUS | INJECTABLE | INTRAVENOUS | MULTIHANCE | BRACCO | 7.935GM/15ML (529MG/ML) | | [] | 2004-11-23 | Nov 23, 2004 | No | Yes | Yes | RX | BRACCO DIAGNOSTICS INC | f3f57a2aab0b66c9061ac03fa101682b2f036bc1cd1d7b5c7565c88bd506f977 |
| 14722 | N | 021357 | 004 | GADOBENATE DIMEGLUMINE | INJECTABLE;INTRAVENOUS | INJECTABLE | INTRAVENOUS | MULTIHANCE | BRACCO | 10.58GM/20ML (529MG/ML) | | [] | 2004-11-23 | Nov 23, 2004 | No | Yes | Yes | RX | BRACCO DIAGNOSTICS INC | b3c193fefe9dd1a81a122c05020bc8c126cb89ba382f2d99eea6d683fc53c74a |
| 14723 | N | 021358 | 001 | GADOBENATE DIMEGLUMINE | INJECTABLE;INTRAVENOUS | INJECTABLE | INTRAVENOUS | MULTIHANCE MULTIPACK | BRACCO | 26.45GM/50ML (529MG/ML) | | [] | 2004-11-23 | Nov 23, 2004 | No | Yes | Yes | RX | BRACCO DIAGNOSTICS INC | de08767a5beed26e7d5eaf168bc741465d5dba22b389109a7779fe6013252be7 |
| 14724 | N | 021358 | 002 | GADOBENATE DIMEGLUMINE | INJECTABLE;INTRAVENOUS | INJECTABLE | INTRAVENOUS | MULTIHANCE MULTIPACK | BRACCO | 52.9GM/100ML (529MG/ML) | | [] | 2004-11-23 | Nov 23, 2004 | No | Yes | Yes | RX | BRACCO DIAGNOSTICS INC | 51e8800112ac1574ac924241bd6684dfb576142a4142b022a23fc0fb73422216 |
| 14725 | N | 021506 | 002 | MICAFUNGIN SODIUM | INJECTABLE;INTRAVENOUS | INJECTABLE | INTRAVENOUS | MYCAMINE | ASTELLAS | EQ 50MG BASE/VIAL | AP | ["AP"] | 2005-03-16 | Mar 16, 2005 | No | Yes | Yes | RX | ASTELLAS PHARMA US INC | e5a69d6401eee66a681f4ed7f8c6283d1f9e1abb962669e8dacd0f6a479b6735 |
| 14726 | N | 021506 | 003 | MICAFUNGIN SODIUM | INJECTABLE;INTRAVENOUS | INJECTABLE | INTRAVENOUS | MYCAMINE | ASTELLAS | EQ 100MG BASE/VIAL | AP | ["AP"] | 2006-06-27 | Jun 27, 2006 | No | Yes | Yes | RX | ASTELLAS PHARMA US INC | 7c4454b0c861977474a7501a2d7b5fe31588093c6520aac50e65d4f12fcd50c7 |
| 14727 | N | 021903 | 001 | IBUPROFEN LYSINE | INJECTABLE;INTRAVENOUS | INJECTABLE | INTRAVENOUS | NEOPROFEN | RECORDATI RARE | EQ 20MG BASE/2ML (EQ 10MG BASE/ML) | AP | ["AP"] | 2006-04-13 | Apr 13, 2006 | No | Yes | Yes | RX | RECORDATI RARE DISEASES INC | 1b159087c3762cf4a3e773b3f2c42f227fb2e188a02e752c822c98502307ffde |
| 14728 | N | 021689 | 001 | ESOMEPRAZOLE SODIUM | INJECTABLE;INTRAVENOUS | INJECTABLE | INTRAVENOUS | NEXIUM IV | ASTRAZENECA | EQ 20MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | | [] | 2005-03-31 | Mar 31, 2005 | No | Yes | No | DISCN | ASTRAZENECA PHARMACEUTICALS LP | 8620159bc1842439ddefe526a87410ad9f5bc82b735e2fe98a4fa58d6ec7eb09 |
| 14729 | N | 021689 | 002 | ESOMEPRAZOLE SODIUM | INJECTABLE;INTRAVENOUS | INJECTABLE | INTRAVENOUS | NEXIUM IV | ASTRAZENECA | EQ 40MG BASE/VIAL | AP | ["AP"] | 2005-03-31 | Mar 31, 2005 | No | Yes | Yes | RX | ASTRAZENECA PHARMACEUTICALS LP | 6f14992e376d9598bccba4d88e96d46cb61d5334037b4607e7443742f4392f0f |
| 14730 | N | 022276 | 002 | NICARDIPINE HYDROCHLORIDE | INJECTABLE;INTRAVENOUS | INJECTABLE | INTRAVENOUS | NICARDIPINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDE | EXELA PHARMA SCIENCE | 20MG/200ML (0.1MG/ML) | | [] | 2016-04-07 | Apr 7, 2016 | No | Yes | Yes | RX | EXELA PHARMA SCIENCES | 86d98f6ea45b12e667368e1d446e7acfc98a1f000f21c2b86eb24e53e0bf7006 |
| 14731 | N | 022276 | 003 | NICARDIPINE HYDROCHLORIDE | INJECTABLE;INTRAVENOUS | INJECTABLE | INTRAVENOUS | NICARDIPINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDE | EXELA PHARMA SCIENCE | 40MG/200ML (0.2MG/ML) | | [] | 2016-04-07 | Apr 7, 2016 | No | Yes | Yes | RX | EXELA PHARMA SCIENCES | 8c5f3b7f419a01475e08627611e2be6c13e1be9032147542ca9a59a741c5cd44 |
| 14732 | A | 207474 | 001 | OXALIPLATIN | INJECTABLE;INTRAVENOUS | INJECTABLE | INTRAVENOUS | OXALIPLATIN | ACCORD HLTHCARE | 50MG/10ML (5MG/ML) | AP | ["AP"] | 2017-03-21 | Mar 21, 2017 | No | No | No | RX | ACCORD HEALTHCARE INC | 6e01de2cf7c80cbc2b02665b195f5e5c21efcdaeaf7a04191f434d58d46b9a89 |
| 14733 | A | 207474 | 002 | OXALIPLATIN | INJECTABLE;INTRAVENOUS | INJECTABLE | INTRAVENOUS | OXALIPLATIN | ACCORD HLTHCARE | 100MG/20ML (5MG/ML) | AP | ["AP"] | 2017-03-21 | Mar 21, 2017 | No | No | No | RX | ACCORD HEALTHCARE INC | 792fbbaa216bd405ea941046741764a0cd76dc6ac76498dd33aa8547e37ac3c5 |
| 14734 | A | 207474 | 003 | OXALIPLATIN | INJECTABLE;INTRAVENOUS | INJECTABLE | INTRAVENOUS | OXALIPLATIN | ACCORD HLTHCARE | 200MG/40ML (5MG/ML) | | [] | 2017-03-21 | Mar 21, 2017 | No | No | No | DISCN | ACCORD HEALTHCARE INC | d28c2cadc93ba80ea81c9bd305b15d65373975d3fc7951891453fdb42df76f54 |
| 14735 | A | 204880 | 001 | OXALIPLATIN | INJECTABLE;INTRAVENOUS | INJECTABLE | INTRAVENOUS | OXALIPLATIN | ACTAVIS LLC | 50MG/10ML (5MG/ML) | AP | ["AP"] | 2018-03-05 | Mar 5, 2018 | No | No | No | RX | ACTAVIS LLC AN INDIRECT WHOLLY-OWNED SUB OF TEVA PHARMACEUTICALS USA INC | 72a78ad22a0ec86e4285353b754f2795bc3ab489b043bf9f2fd7490a0dc66f2a |
| 14736 | A | 204880 | 002 | OXALIPLATIN | INJECTABLE;INTRAVENOUS | INJECTABLE | INTRAVENOUS | OXALIPLATIN | ACTAVIS LLC | 100MG/20ML (5MG/ML) | AP | ["AP"] | 2018-03-05 | Mar 5, 2018 | No | No | No | RX | ACTAVIS LLC AN INDIRECT WHOLLY-OWNED SUB OF TEVA PHARMACEUTICALS USA INC | 85d9611765cc97187d2a936df5471c380a7582163906721193819a4b4160dabc |
| 14737 | A | 078803 | 001 | OXALIPLATIN | INJECTABLE;INTRAVENOUS | INJECTABLE | INTRAVENOUS | OXALIPLATIN | ACTAVIS TOTOWA | 50MG/VIAL | AP | ["AP"] | 2012-08-08 | Aug 8, 2012 | No | No | Yes | RX | ACTAVIS TOTOWA LLC | 91eff32d3d8ee47b14e2e0761da7f4ae8b7e3043b517969035a1f0e24f377129 |
| 14738 | A | 078803 | 002 | OXALIPLATIN | INJECTABLE;INTRAVENOUS | INJECTABLE | INTRAVENOUS | OXALIPLATIN | ACTAVIS TOTOWA | 100MG/VIAL | AP | ["AP"] | 2012-08-08 | Aug 8, 2012 | No | No | Yes | RX | ACTAVIS TOTOWA LLC | 9a89977c645acbd883609cf9aa4b431ac804f2e8341037f6e6b87ad026683faf |
| 14739 | A | 204378 | 001 | OXALIPLATIN | INJECTABLE;INTRAVENOUS | INJECTABLE | INTRAVENOUS | OXALIPLATIN | AM REGENT | 50MG/10ML (5MG/ML) | | [] | 2017-05-12 | May 12, 2017 | No | No | No | DISCN | AMERICAN REGENT INC | d00d807f08291589b25aad5cea6319dd6e1b3ef5c61f0d2743affde076afd43e |
| 14740 | A | 204378 | 002 | OXALIPLATIN | INJECTABLE;INTRAVENOUS | INJECTABLE | INTRAVENOUS | OXALIPLATIN | AM REGENT | 100MG/20ML (5MG/ML) | | [] | 2017-05-12 | May 12, 2017 | No | No | No | DISCN | AMERICAN REGENT INC | 73476d999f649421a07d705c16bb1e6c5c407b6dc81b8e870823f235769fd23e |
| 14741 | A | 208523 | 001 | OXALIPLATIN | INJECTABLE;INTRAVENOUS | INJECTABLE | INTRAVENOUS | OXALIPLATIN | CIPLA | 50MG/10ML (5MG/ML) | AP | ["AP"] | 2017-02-10 | Feb 10, 2017 | No | No | No | RX | CIPLA LTD | 2e9a5488fd8128086c5aa536e5054644cca53154861e4b82793c864722af6cc2 |
| 14742 | A | 208523 | 002 | OXALIPLATIN | INJECTABLE;INTRAVENOUS | INJECTABLE | INTRAVENOUS | OXALIPLATIN | CIPLA | 100MG/20ML (5MG/ML) | AP | ["AP"] | 2017-02-10 | Feb 10, 2017 | No | No | No | RX | CIPLA LTD | 342aaa80fd357403fe8e782f0dafd4d56878d83394ced16263b91053c368d37d |
| 14743 | A | 205529 | 001 | OXALIPLATIN | INJECTABLE;INTRAVENOUS | INJECTABLE | INTRAVENOUS | OXALIPLATIN | EUGIA PHARMA | 50MG/10ML (5MG/ML) | AP | ["AP"] | 2017-09-06 | Sep 6, 2017 | No | No | No | RX | EUGIA PHARMA SPECIALITIES LTD | 010df905ece86ca022f3974231c59f994a2496aa1f3787d3c96c43569506802c |
| 14744 | A | 205529 | 002 | OXALIPLATIN | INJECTABLE;INTRAVENOUS | INJECTABLE | INTRAVENOUS | OXALIPLATIN | EUGIA PHARMA | 100MG/20ML (5MG/ML) | AP | ["AP"] | 2017-09-06 | Sep 6, 2017 | No | No | No | RX | EUGIA PHARMA SPECIALITIES LTD | 0618ca8c72505d76b6bf1e147681fda6d8ab4e7f1c61a50faa31d58f6aec3121 |
| 14745 | A | 078810 | 001 | OXALIPLATIN | INJECTABLE;INTRAVENOUS | INJECTABLE | INTRAVENOUS | OXALIPLATIN | FRESENIUS KABI ONCOL | 50MG/VIAL | | [] | 2009-08-07 | Aug 7, 2009 | No | No | No | DISCN | FRESENIUS KABI ONCOLOGY PLC | da884378325852c033b1792b61ac36a60028a3f8a49eedbfeec9c9d782ae9613 |
| 14746 | A | 078810 | 002 | OXALIPLATIN | INJECTABLE;INTRAVENOUS | INJECTABLE | INTRAVENOUS | OXALIPLATIN | FRESENIUS KABI ONCOL | 100MG/VIAL | | [] | 2009-08-07 | Aug 7, 2009 | No | No | No | DISCN | FRESENIUS KABI ONCOLOGY PLC | 28801feca6c1d6f025a444d14b45c99507b100cd24ddd45ff1910b319028cc6a |
| 14747 | A | 078811 | 001 | OXALIPLATIN | INJECTABLE;INTRAVENOUS | INJECTABLE | INTRAVENOUS | OXALIPLATIN | FRESENIUS KABI USA | 50MG/10ML (5MG/ML) | AP | ["AP"] | 2010-06-10 | Jun 10, 2010 | No | No | No | RX | FRESENIUS KABI USA LLC | a5f5392eb5337012aef7a1b1cae460e6e5e680acfe89cd93a24027276b9699fb |
| 14748 | A | 078811 | 002 | OXALIPLATIN | INJECTABLE;INTRAVENOUS | INJECTABLE | INTRAVENOUS | OXALIPLATIN | FRESENIUS KABI USA | 100MG/20ML (5MG/ML) | AP | ["AP"] | 2010-06-10 | Jun 10, 2010 | No | No | No | RX | FRESENIUS KABI USA LLC | 2d27b07858aeefbe74a01b730c6870cd33f4723ed9a97ad2b5843bc254c7b4bc |
| 14749 | A | 078819 | 001 | OXALIPLATIN | INJECTABLE;INTRAVENOUS | INJECTABLE | INTRAVENOUS | OXALIPLATIN | FRESENIUS KABI USA | 50MG/VIAL | AP | ["AP"] | 2010-06-02 | Jun 2, 2010 | No | No | No | RX | FRESENIUS KABI USA LLC | 4aa7906f7902614344ce743edabc696567c5b046f3cedb174435f5a1a9f4141b |
| 14750 | A | 090030 | 001 | OXALIPLATIN | INJECTABLE;INTRAVENOUS | INJECTABLE | INTRAVENOUS | OXALIPLATIN | FRESENIUS KABI USA | 50MG/10ML (5MG/ML) | AP | ["AP"] | 2017-01-31 | Jan 31, 2017 | No | No | No | RX | FRESENIUS KABI USA LLC | d9feab749e5d9d1f9a48211d444f1cb0fcc00896e066d7825730606bb9e536ac |
| 14751 | A | 078819 | 002 | OXALIPLATIN | INJECTABLE;INTRAVENOUS | INJECTABLE | INTRAVENOUS | OXALIPLATIN | FRESENIUS KABI USA | 100MG/VIAL | AP | ["AP"] | 2010-06-02 | Jun 2, 2010 | No | No | No | RX | FRESENIUS KABI USA LLC | 8a7ab51f4fe40bf2460bc65fa86193c353a4ed3ad8cf578e3100c4e8a0281da3 |